ArticleCancer immunology, immunotherapy : CII2025

PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny.

Mohammad A Alzubi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.